Some authors hypothesize that these metabolically unhealthy lean subjects could have a lipodystrophy-like phenotype, resulting in a higher risk to develop NAFLD, insulin resistance and impaired insulin secretion (235). This evidence concerns the gene INS and metabolic dysfunction-associated steatotic liver disease.